HUP0002316A2 - Gyorsan olvadó orális adagolási formák - Google Patents

Gyorsan olvadó orális adagolási formák

Info

Publication number
HUP0002316A2
HUP0002316A2 HU0002316A HUP0002316A HUP0002316A2 HU P0002316 A2 HUP0002316 A2 HU P0002316A2 HU 0002316 A HU0002316 A HU 0002316A HU P0002316 A HUP0002316 A HU P0002316A HU P0002316 A2 HUP0002316 A2 HU P0002316A2
Authority
HU
Hungary
Prior art keywords
granules
flash
oral dosage
dosage formulation
subject
Prior art date
Application number
HU0002316A
Other languages
English (en)
Inventor
Divyakant S. Desai
Sanjeev H. Kothari
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24186805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002316(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HU0002316D0 publication Critical patent/HU0002316D0/hu
Publication of HUP0002316A2 publication Critical patent/HUP0002316A2/hu
Publication of HUP0002316A3 publication Critical patent/HUP0002316A3/hu
Publication of HU228864B1 publication Critical patent/HU228864B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A találmány tárgyát gyorsan olvadó gyógyszerészeti adagolási formákelőállítására szolgáló granulák képezik. Egy vagy több gyógyszerenkívül a granulák egy segédanyag-kombinációt tartalmaznak, amely egyszuperdezintegrátorból, egy diszpergálószerből, egy eloszlató ágensbőlés egy kötőanyagból áll, de tartalmazhatnak egyéb szokásosadalékanyagokat, így édesítő és ízesítő anyagokat is. A tárgy szerintigranulák előnye, hogy ezek stabilak, oldószerek segítsége nélkül előlehet ezeket állítani, és különleges körülményeket vagy kezelést nemigényelnek. Az ezekből a granulákból a szokásos berendezésekkelelőállított adagolási formák, különösen a tabletták, a szájban mintegy20 másodpercen belül szétesnek. Ó
HU0002316A 2000-04-12 2000-06-19 Flash-melt oral dosage formulation HU228864B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54794800A 2000-04-12 2000-04-12

Publications (4)

Publication Number Publication Date
HU0002316D0 HU0002316D0 (en) 2000-08-28
HUP0002316A2 true HUP0002316A2 (hu) 2002-11-28
HUP0002316A3 HUP0002316A3 (en) 2008-04-28
HU228864B1 HU228864B1 (en) 2013-06-28

Family

ID=24186805

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002316A HU228864B1 (en) 2000-04-12 2000-06-19 Flash-melt oral dosage formulation

Country Status (43)

Country Link
US (3) US20100016448A1 (hu)
EP (2) EP1145711B1 (hu)
JP (1) JP3773763B2 (hu)
KR (1) KR100477293B1 (hu)
CN (1) CN100353933C (hu)
AR (1) AR024384A1 (hu)
AT (1) ATE328584T1 (hu)
AU (1) AU752214B2 (hu)
BG (1) BG65007B1 (hu)
BR (1) BR0003158A (hu)
CA (1) CA2311734C (hu)
CO (1) CO5190672A1 (hu)
CY (1) CY1105170T1 (hu)
CZ (1) CZ299145B6 (hu)
DE (1) DE60028536T2 (hu)
DK (1) DK1145711T3 (hu)
EE (1) EE04331B1 (hu)
EG (1) EG23943A (hu)
ES (1) ES2265836T3 (hu)
GE (1) GEP20022851B (hu)
HK (1) HK1039572B (hu)
HU (1) HU228864B1 (hu)
ID (1) ID29837A (hu)
IL (1) IL136901A (hu)
IN (1) IN188856B (hu)
LT (1) LT4896B (hu)
LV (1) LV12731B (hu)
MY (1) MY125766A (hu)
NO (1) NO330270B1 (hu)
NZ (1) NZ505302A (hu)
PE (1) PE20010298A1 (hu)
PL (1) PL200409B1 (hu)
PT (1) PT1145711E (hu)
RO (1) RO118563B1 (hu)
RU (1) RU2201216C2 (hu)
SG (2) SG117445A1 (hu)
SI (1) SI20511B (hu)
SK (1) SK286368B6 (hu)
TR (1) TR200001810A2 (hu)
TW (1) TWI262799B (hu)
UA (1) UA63993C2 (hu)
UY (1) UY26306A1 (hu)
ZA (1) ZA200003121B (hu)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030868A1 (en) 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
MY129350A (en) * 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
MY138669A (en) * 2001-09-25 2009-07-31 Otsuka Pharma Co Ltd Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
RS55392B1 (sr) * 2001-10-09 2017-03-31 Otsuka Pharma Co Ltd Brzo topljiva formulacija za oralno doziranje
US6610266B2 (en) 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making
WO2003050110A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Ltd. Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
AU2003238670A1 (en) * 2002-04-05 2003-10-27 Cadila Healthcare Limited Fast disintegrating oral dosage forms
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
DK1542668T3 (da) 2002-08-20 2009-07-20 Bristol Myers Squibb Co Formulering af aripiprazolkompleks og fremgangsmåde
IN2012DN00604A (hu) * 2002-12-11 2015-08-21 Bristol Myers Squibb Co
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
PL1750862T3 (pl) 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
JP3996626B2 (ja) * 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
KR20140065482A (ko) * 2005-03-24 2014-05-29 다이이찌 산쿄 가부시키가이샤 의약용 조성물
WO2007081366A1 (en) 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Wet granulation pharmaceutical compositions of aripiprazole
DK1808165T3 (da) * 2006-01-05 2009-08-03 Teva Pharma Törre formuleringer af aripiprazol
PL1806130T3 (pl) * 2006-01-09 2010-08-31 Krka D D Novo Mesto Kompozycja farmaceutyczna w postaci stałej zawierająca irbesartan
US20090208576A1 (en) * 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
WO2008125388A1 (en) * 2007-04-17 2008-10-23 Ratiopharm Gmbh Pharmaceutical compositions comprising irbesartan
ES2745438T3 (es) * 2007-05-08 2020-03-02 Hercules Llc Formulación robusta de comprimidos de desintegración rápida
CN101322709B (zh) * 2007-06-12 2011-03-02 成都康弘药业集团股份有限公司 一种含有阿立哌唑的药物组合物及其制备方法
KR101784647B1 (ko) * 2008-05-02 2017-10-11 길리애드 사이언시즈, 인코포레이티드 제약 제제의 가공성 향상을 위한 고체 담체 입자의 용도
JP5296456B2 (ja) * 2008-08-26 2013-09-25 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
US20120004321A1 (en) * 2009-03-16 2012-01-05 Nipro Corporation Orally Disintegrating Tablet
WO2010146551A2 (en) * 2009-06-16 2010-12-23 Ranbaxy Laboratories Limited Orally disintegrating compositions comprising antihypertensive agents
US20120214820A1 (en) 2009-09-15 2012-08-23 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
TR201000689A1 (tr) * 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Sefprozil içeren katı dozaj formlar.
CN102218040A (zh) * 2010-04-13 2011-10-19 齐鲁制药有限公司 一种阿立哌唑组合物微晶的口腔崩解片及其制备方法
EP2384742A1 (en) 2010-05-03 2011-11-09 The Jordanian Pharmaceutical Manufacturing Co. Pharmaceutical excipient, method for its preparation and use thereof
DE102010019416A1 (de) * 2010-05-04 2011-11-10 Stada Arzneimittel Ag Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum
HU1000278D0 (en) 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
RS65237B1 (sr) 2011-03-18 2024-03-29 Alkermes Pharma Ireland Ltd Farmaceutske kompozicije koje sadrže sorbitan estre
CA2830591C (en) * 2011-03-21 2024-02-13 Coloright Ltd. Systems for custom coloration
GB2505860B (en) * 2011-06-27 2018-10-31 Shanghai Zhongxi Pharmaceutical Corp Aripiprazole medicament formulation and preparation method therefor
CN102846564B (zh) * 2011-06-28 2013-10-09 南京亿华药业有限公司 一种头孢丙烯片及其制法
CN102357086A (zh) * 2011-11-01 2012-02-22 上海理工大学 一种头孢丙烯口腔崩解片
JP2015504878A (ja) * 2011-12-26 2015-02-16 ノバルティス アーゲー 錠剤及び有核剤
ES2764383T3 (es) 2012-03-19 2020-06-03 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden ésteres de glicerol
US10004807B2 (en) 2012-03-19 2018-06-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty acid esters
CA2867137C (en) 2012-03-19 2020-12-08 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol
WO2013175508A2 (en) 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
CA2779052A1 (en) * 2012-05-31 2013-11-30 Pharmascience Inc. Pharmaceutical composition of entecavir and process of manufacturing
KR101571670B1 (ko) 2012-08-08 2015-11-25 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제
WO2014030172A2 (en) * 2012-08-23 2014-02-27 Hetero Research Foundation Pharmaceutical formulations of rufinamide
EP2897592B1 (en) 2012-09-19 2020-02-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions having improved storage stability
CN102885790B (zh) * 2012-09-20 2013-12-25 中国人民解放军第三〇二医院 恩替卡韦分散片及其制备方法
WO2014178334A1 (en) 2013-04-30 2014-11-06 Otsuka Pharmaceutical Co., Ltd. Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
JP5714652B2 (ja) * 2013-06-13 2015-05-07 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2015067313A1 (en) 2013-11-07 2015-05-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole
EP3119399A4 (en) 2014-03-20 2017-09-27 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
JP5978335B2 (ja) * 2015-03-11 2016-08-24 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
KR20160139704A (ko) 2015-05-28 2016-12-07 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제, 및 이의 제조방법
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
US9855227B2 (en) 2015-12-18 2018-01-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
TR201617675A2 (tr) 2016-12-02 2018-06-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Ari̇pi̇prazole monohi̇drat formülasyonlarinin ağizda dağilan tablet formu
JP6572257B2 (ja) * 2017-05-16 2019-09-04 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
JP2017141299A (ja) * 2017-05-24 2017-08-17 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
JP2018168185A (ja) * 2018-07-05 2018-11-01 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2019203031A (ja) * 2019-09-06 2019-11-28 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
RU2732291C1 (ru) * 2020-02-13 2020-09-15 Открытое акционерное общество "Фармстандарт-Лексредства" (ОАО "Фармстандарт-Лексредства") Лекарственный препарат на основе травы алтея лекарственного для лечения простудных и острых респираторных заболеваний
GB2617603A (en) * 2022-04-13 2023-10-18 Univ Brunel Compositions for preventing and treating infection
CN115227661B (zh) * 2022-09-22 2022-12-13 北京惠之衡生物科技有限公司 一种利格列汀片及其制备方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1912354B2 (de) * 1969-03-12 1972-04-13 Reimbold & Strick, 5000 Köln-Kalk Synthetisches kristallines calciumsilikat und verfahren zu seiner herstellung
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
FR2234244B1 (hu) * 1973-06-20 1978-02-17 Rech Geolog Miniere
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE2849494A1 (de) 1978-11-15 1980-05-29 Voss Gunter M Verfahren zur herstellung von arzneimittel-formlingen
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
ZA87279B (en) 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
SE8601624D0 (sv) 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US5032552A (en) * 1988-07-04 1991-07-16 Tdk Corporation Biomedical material
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
HU203041B (en) 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
JPH06271744A (ja) * 1993-03-22 1994-09-27 Mizusawa Ind Chem Ltd ポリアセタール系樹脂用帯電防止剤
US5393472A (en) * 1993-06-30 1995-02-28 Shaw; John D. Method of producing wollastonite & ceramic bodies containing wollastonite
IL110376A (en) * 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical preparations containing iftroban and methods for their preparation
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US6103007A (en) * 1995-11-17 2000-08-15 Vrije Universiteit Brussel Inorganic resin compositions, their preparation and use thereof
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
PT890359E (pt) * 1996-02-29 2003-03-31 Fujisawa Pharmaceutical Co Comprimidos que contem antibiotico de beta-lactama e processo para a sua preparacao
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DE69732909T2 (de) * 1996-07-12 2005-08-11 Daiichi Pharmaceutical Co., Ltd. Rasch zerfallende Pressmasse und Verfahren zu ihrer Herstellung
CA2258917A1 (en) * 1996-07-23 1998-01-29 Fmc Corporation Disintegrant composition for dispersible solids
JPH10114655A (ja) 1996-10-09 1998-05-06 Kyowa Hakko Kogyo Co Ltd 固形製剤
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
AUPO446397A0 (en) 1997-01-07 1997-01-30 Rees Equipment Pty Ltd Agricultural equipment direction control
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11152220A (ja) * 1997-11-19 1999-06-08 Daiichi Yakuhin Kogyo Kk 脂溶性薬物を含有した丸剤の製造方法
PL197989B1 (pl) * 1997-12-19 2008-05-30 Smithkline Beecham Corp Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
NZ507271A (en) 1998-03-06 2003-03-28 Eurand Internat S Fast disintegrating tablets
JP4027535B2 (ja) 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
CO5070643A1 (es) * 1998-05-27 2001-08-28 Merck & Co Inc Formulacion en tabletas comprimidas
JP2000119014A (ja) 1998-08-12 2000-04-25 Fuji Chem Ind Co Ltd 無晶形ケイ酸アルミン酸カルシウム複合酸化物及びその製造方法並びに制酸剤
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US6133378A (en) * 1998-11-20 2000-10-17 Bridgestone/Firestone, Inc. EPDM-based roofing shingle compositions
GB9914936D0 (en) 1999-06-26 1999-08-25 Cerestar Holding Bv Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
CA2447341A1 (en) 2001-06-29 2003-01-09 Xanoptix, Inc. Post-formation feature optimization
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
US6610266B2 (en) * 2001-11-28 2003-08-26 Michael C. Withiam Calcium metasilicates and methods for making

Also Published As

Publication number Publication date
LV12731B (en) 2002-03-20
ES2265836T3 (es) 2007-03-01
PE20010298A1 (es) 2001-05-20
EP1145711A1 (en) 2001-10-17
NO20003196L (no) 2001-10-15
LT4896B (lt) 2002-02-25
US9358207B2 (en) 2016-06-07
HK1039572A1 (en) 2002-05-03
HUP0002316A3 (en) 2008-04-28
IL136901A (en) 2008-03-20
NO330270B1 (no) 2011-03-14
DE60028536D1 (de) 2006-07-20
US8518421B2 (en) 2013-08-27
BG65007B1 (bg) 2006-12-29
HK1039572B (zh) 2007-01-12
SI20511A (sl) 2001-10-31
AU4373300A (en) 2001-10-18
BG104693A (en) 2002-02-28
EP1145711B1 (en) 2006-06-07
CN100353933C (zh) 2007-12-12
US20100016448A1 (en) 2010-01-21
CZ299145B6 (cs) 2008-04-30
AU752214B2 (en) 2002-09-12
KR20010096450A (ko) 2001-11-07
CZ20002391A3 (cs) 2001-11-14
GEP20022851B (en) 2002-12-25
SG117445A1 (en) 2005-12-29
CA2311734A1 (en) 2001-10-12
DK1145711T3 (da) 2006-10-02
TWI262799B (en) 2006-10-01
US20130296337A1 (en) 2013-11-07
IL136901A0 (en) 2001-06-14
CN1317309A (zh) 2001-10-17
JP3773763B2 (ja) 2006-05-10
SK286368B6 (sk) 2008-08-05
CA2311734C (en) 2011-03-08
UA63993C2 (uk) 2004-02-16
LV12731A (en) 2001-10-20
TR200001810A3 (tr) 2001-11-21
RU2201216C2 (ru) 2003-03-27
DE60028536T2 (de) 2007-05-16
KR100477293B1 (ko) 2005-03-17
EP1566174A2 (en) 2005-08-24
EE04331B1 (et) 2004-08-16
ID29837A (id) 2001-10-18
NO20003196D0 (no) 2000-06-20
JP2001302499A (ja) 2001-10-31
UY26306A1 (es) 2001-12-28
BR0003158A (pt) 2001-12-18
ZA200003121B (en) 2001-12-21
RO118563B1 (ro) 2003-07-30
SG108230A1 (en) 2005-01-28
PL200409B1 (pl) 2009-01-30
IN188856B (hu) 2002-11-16
SI20511B (sl) 2008-08-31
AR024384A1 (es) 2002-10-02
HU0002316D0 (en) 2000-08-28
MY125766A (en) 2006-08-30
EE200000497A (et) 2001-12-17
TR200001810A2 (tr) 2001-11-21
PT1145711E (pt) 2006-11-30
HU228864B1 (en) 2013-06-28
SK9732000A3 (en) 2001-11-06
ATE328584T1 (de) 2006-06-15
CO5190672A1 (es) 2002-08-29
LT2000064A (en) 2001-10-25
PL341466A1 (en) 2001-10-22
EP1566174A3 (en) 2007-04-04
CY1105170T1 (el) 2010-03-03
NZ505302A (en) 2001-12-21
EG23943A (en) 2008-01-22
US20110217342A1 (en) 2011-09-08

Similar Documents

Publication Publication Date Title
HUP0002316A2 (hu) Gyorsan olvadó orális adagolási formák
HUP0402004A2 (hu) Módosított hatóanyag-leadású tamszulozintabletták
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
TR200002207T1 (tr) Slekoksib bileşikleri.
HUP0000138A2 (hu) Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
HUP0101411A2 (hu) 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása
HUP0203162A2 (hu) NSAID és EGFR-kináz gátlót tartalmazó készítmény vastagbélpolipok és vastagbélrák kezelésére vagy visszaszorítására
HUP0003848A2 (hu) Budesonid és formoterol új alkalmazása
FR2727016B1 (fr) Compositions pharmaceutiques a base d'ondansetron
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
MY127350A (en) Flash-melt oral dose formulations
HUP0401195A2 (hu) Averziót okozó szert tartalmazó készítmények opioidokkal való visszaélés megakadályozására
HUP0102206A2 (hu) Delavirdint tartalmazó tabletta formájú készítmény
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
BG105173A (en) Novel salt form of pantoprazole
HUP0202862A2 (hu) A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény
HUP0202781A2 (hu) Béta-karbolin szemcsés formája, ezt tartalmazó gyógyszerkészítmények, előállításaik és alkalmazásuk
HUP0402492A2 (hu) 5HT4 részleges agonistát tartalmazó gyógyszerkészítmények
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HUP0004363A2 (hu) Miltefosint tartalmazó orális szilárd gyógyszerkészítmények leishmaniasis kezelésére
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
HUP0402178A2 (hu) 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény